Zhejiang Orient Gene Biotech Co Ltd Cash Flow-to-Debt Ratio
Zhejiang Orient Gene Biotech Co Ltd cash flow-to-debt ratio. Zhejiang Orient Gene Biotech Co Ltd (688298) has a Cash Flow-to-Debt Ratio of -0.03x as of September 2025, meaning its operating cash flow of CN¥-30.52 Million could theoretically repay 0% of its total liabilities (CN¥1.01 Billion) in one year. Check 688298 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Zhejiang Orient Gene Biotech Co Ltd (2016–2024)
Cash flow-to-debt ratio of Zhejiang Orient Gene Biotech Co Ltd from 2016 to 2024. Historical debt coverage capacity for Zhejiang Orient Gene Biotech Co Ltd across 9 annual periods. Check how high is Zhejiang Orient Gene Biotech Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Zhejiang Orient Gene Biotech Co Ltd Cash Flow-to-Debt Ratio by Year (2016–2024)
Zhejiang Orient Gene Biotech Co Ltd cash flow-to-debt ratio by year from 2016 to 2024. Year-by-year debt coverage analysis for Zhejiang Orient Gene Biotech Co Ltd. For the full cash flow conversion analysis, see Zhejiang Orient Gene Biotech Co Ltd cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.27x | CN¥-348.33 Million | CN¥1.30 Billion | ▲ +75.9% |
| 2023 | -1.11x | CN¥-1.60 Billion | CN¥1.45 Billion | ▼ -188.0% |
| 2022 | 1.26x | CN¥3.00 Billion | CN¥2.38 Billion | ▼ -49.5% |
| 2021 | 2.49x | CN¥5.20 Billion | CN¥2.09 Billion | ▲ +56.2% |
| 2020 | 1.60x | CN¥1.79 Billion | CN¥1.12 Billion | ▲ +216.1% |
| 2019 | 0.50x | CN¥54.21 Million | CN¥107.38 Million | ▲ +47.6% |
| 2018 | 0.34x | CN¥44.33 Million | CN¥129.62 Million | ▲ +23.6% |
| 2017 | 0.28x | CN¥33.54 Million | CN¥121.20 Million | ▲ +233.5% |
| 2016 | 0.08x | CN¥11.81 Million | CN¥142.28 Million | — |